Aileron Therapeutics Inc (ALRN)

Finanzdaten der Aileron Therapeutics Inc-Aktie (ALRN)

Gewinn- und Verlustrechnung

Vierteljährlich

*Alle Zahlen in Millionen

Enddatum des Zeitraums	2024-03-31	2023-12-31	2023-09-30	2023-06-30	2023-03-31
Periodenlänge	3 Monate	3 Monate	3 Monate	3 Monate	3 Monate
Revenues	-	-	-	-	-
Operating Expenses	1.17% 7.205	7.29	1.983	1.992	5.011
Operating Income/Loss	1.17% -7.205	-7.29	-1.983	-1.992	-5.011
Income/Loss From Continuing Operations Before Tax	3.08% -7.113	-7.339	-1.827	-1.787	-4.779
Income/Loss From Continuing Operations After Tax	3.08% -7.113	-7.339	-1.827	-1.787	-4.779
Net Income/Loss	3.08% -7.113	-7.339	-1.827	-1.787	-4.779
Preferred Stock Dividends And Other Adjustments	-	-	-	-	-
Attributable To Noncontrolling Interest	-	-	-	-	-
Basic Average Shares	14,326% 8.3018	0.0575	4.5412	4.5412	4.5412
Diluted Average Shares	14,326% 8.3018	0.0575	4.5412	4.5412	4.5412
Basic Earnings Per Share	45.22% -0.86	-1.57	-0.40	-0.39	-1.05
Diluted Earnings Per Share	45.22% -0.86	-1.57	-0.40	-0.39	-1.05
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic	-	-	-	-	-